3M Company (MMM) SEC Filings & Earnings Calls

PFAS litigation exposure

“Extensive litigation note detailing multiple PFAS-related lawsuits, settlements, and environmental remediation obligations.”

AFFF litigation exposure

“AFFF MDL personal injury bellwether cases and PWS settlement with minimum $10.3 billion and maximum $12.5 billion.”

Restructuring execution risk

“Transformation program with $145 million pre-tax charge in 9M 2026, additional actions expected.”

Divestiture losses

“Loss on business divestitures $343 million for 9M 2026, including $324 million from Dyneon GmbH divestiture.”

GAAP organic sales growth was only 0.2%, significantly below adjusted organic growth of 3.3%, suggesting divestitures and other adjustments mask underlying weakness.

“Organic sales up 0.2% year-on-year (GAAP) vs adjusted organic sales up 3.3%”

Litigation and PFAS exit costs continue to impact GAAP results, with $0.19 per share in net costs.

“Net costs for significant litigation and PFAS exit of $0.19”

Dependence on Amazon achieving payment milestones

“85% of Warrant Shares vest subject to payments from Amazon”

Debt issuance increases leverage, though used for refinancing.

“Proceeds used for general corporate purposes, which may include repayment, redemption or refinancing of indebtedness.”

Insufficient detail to assess risk; termination of credit agreement could indicate refinancing or liquidity change.

“termination of the Former Revolving Credit Agreement” · word for word

PFAS Litigation Exposure

“The Company and certain of its subsidiaries are involved in numerous claims, legal proceedings, and investigations worldwide... The outcomes of legal proceedings and investigations are inherently uncertain, difficult to predict, and could have a material adverse effect on the Company.” · word for word

Divestiture Losses

“The transaction resulted in a $324 million pre-tax loss on business divestiture that was recorded within Corporate.”

Consumer Demand Weakness

“Consumer Business segment 1,247 1,270... Home Improvement 362 374... Packaging and Expression 278 310” · word for word

Litigation and PFAS exit costs continue to impact GAAP results; transformation costs ongoing.

“Net costs for significant litigation and PFAS exit $0.44; Transformation costs $0.15” · word for word

Increased leverage from $1.43B term loan; financial covenant requires EBITDA/Interest >= 3.0x.

“Credit Agreement contains financial covenant requiring EBITDA to Interest Ratio not less than 3.0 to 1.0.”

PFAS litigation exposure

“Extensive litigation related to PFAS (per- and polyfluoroalkyl substances) including PWS Settlement, New Jersey Settlement, and numerous other cases; liabilities recorded but range of possible loss not fully estimable.”

Solventum ownership volatility

“Change in value of retained Solventum common stock swung from $343M gain in Q1 2025 to $356M loss in Q1 2026, creating significant earnings volatility.”

Restructuring execution risk

“Transformation program with $44M additional charge in Q1 2026; additional actions expected subject to future approval.”

Debt and interest expense

“Interest expense $214M in Q1 2026 vs $255M in Q1 2025; new $1.45B term loan facility undrawn as of March 31, 2026, for Madison acquisition.”

PFAS litigation and manufacturing exit costs: $0.18 EPS impact in Q1 from manufactured PFAS products; ongoing liabilities from claims, lawsuits, and regulatory proceedings.

“Manufactured PFAS products $0.18; liabilities and contingencies related to PFAS, including liabilities related to claims, lawsuits, and government regulatory proceedings”

Solventum ownership value volatility: $0.67 increase in value of Solventum ownership in Q1, but this is a non-cash item that can swing significantly.

“(Increase) decrease in value of Solventum ownership $0.67”

Tariff and trade policy uncertainty: Company cites tariffs and retaliatory measures as key risk, though current impact appears manageable.

“worldwide economic, political, regulatory, international trade, geopolitical, tariffs, and retaliatory counter measures” · word for word

Transformation execution risk: $0.09 EPS impact from transformation costs in Q1; ongoing restructuring may disrupt operations.

“Transformation costs $0.09”

PFAS Litigation and Regulatory Liability

“3M will pay $10.5 billion to $12.5 billion in total to resolve the claims released by the PWS Settlement” · word for word

Combat Arms Earplug Settlement

“3M will contribute a total amount of $6.0 billion between 2023 and 2029.” · word for word

Tariff and Trade Restriction Impact

“Tariffs and other trade restrictions may also: increase the cost of raw materials and components imported from other countries” · word for word

Litigation costs (PFAS, etc.) remain significant; GAAP EPS impacted by special items.

“Net costs for significant litigation $0.56 in Q4; manufactured PFAS products $0.39.”